Correlation Between Cyteir Therapeutics and Pardes Biosciences
Can any of the company-specific risk be diversified away by investing in both Cyteir Therapeutics and Pardes Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyteir Therapeutics and Pardes Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyteir Therapeutics and Pardes Biosciences, you can compare the effects of market volatilities on Cyteir Therapeutics and Pardes Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyteir Therapeutics with a short position of Pardes Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyteir Therapeutics and Pardes Biosciences.
Diversification Opportunities for Cyteir Therapeutics and Pardes Biosciences
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Cyteir and Pardes is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Cyteir Therapeutics and Pardes Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pardes Biosciences and Cyteir Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyteir Therapeutics are associated (or correlated) with Pardes Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pardes Biosciences has no effect on the direction of Cyteir Therapeutics i.e., Cyteir Therapeutics and Pardes Biosciences go up and down completely randomly.
Pair Corralation between Cyteir Therapeutics and Pardes Biosciences
If you would invest 214.00 in Pardes Biosciences on September 3, 2024 and sell it today you would earn a total of 0.00 from holding Pardes Biosciences or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Cyteir Therapeutics vs. Pardes Biosciences
Performance |
Timeline |
Cyteir Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Pardes Biosciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Cyteir Therapeutics and Pardes Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cyteir Therapeutics and Pardes Biosciences
The main advantage of trading using opposite Cyteir Therapeutics and Pardes Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyteir Therapeutics position performs unexpectedly, Pardes Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pardes Biosciences will offset losses from the drop in Pardes Biosciences' long position.Cyteir Therapeutics vs. Nuvation Bio | Cyteir Therapeutics vs. Foghorn Therapeutics | Cyteir Therapeutics vs. C4 Therapeutics | Cyteir Therapeutics vs. Prelude Therapeutics |
Pardes Biosciences vs. Shattuck Labs | Pardes Biosciences vs. Eliem Therapeutics | Pardes Biosciences vs. Champions Oncology | Pardes Biosciences vs. Century Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |